Kiliś-Pstrusińska Katarzyna, Medyńska Anna, Zwolińska Danuta, Wawro Anna
Department of Paediatric Nephrology, Wroclaw Medical University, Wrocław, Poland.
Kidney Blood Press Res. 2008;31(2):122-6. doi: 10.1159/000124284. Epub 2008 Apr 7.
BACKGROUND/AIMS: Interleukin (IL)-18, a member of the IL-1 cytokine superfamily, is recognized as an important regulator of immune responses. The aim of our study was to investigate the IL-18 levels in serum and urine from children with idiopathic nephrotic syndrome (INS) during relapse and remission, and to evaluate the role of IL-18 in this disease.
67 children with INS, aged 3-16 years, and 15 normal controls were included in the study. The patients were divided into two groups according to activity of the disease: I (n = 37) - INS in relapse, II (n = 30) - INS in remission. Serum and urinary IL-18 were determined by ELISA and in urine related to the urinary creatinine (Cr) concentration. Serum creatinine, protein, albumin and 24-hour proteinuria were measured in children with INS.
Urinary IL-18 concentration was significantly higher in group I (213.51 +/- 162.15 pg/mg Cr) compared to group II (64.74 +/- 10.95 pg/mg Cr) and to normal controls (37.03 +/- 4.1 pg/mg Cr, p < 0.001). Serum IL-18 concentration was significantly higher in group I than in the controls (146.4 +/- 30.2 and 113 +/- 10 pg/ml, respectively; p < 0.05); the differences between either groups I and II or group II and controls were not significant. Urinary IL-18 correlated positively with serum IL-18 and with urinary protein excretion, but no correlations were found with other laboratory data.
Increased serum and urine IL-18 levels were observed during relapse of INS. These findings indicate the association between the active phase of INS and the levels of IL-18 and can suggest the role of this cytokine in the INS development. The changes in urinary IL-18 excretion in the course of INS are connected with the disease activity.
背景/目的:白细胞介素(IL)-18是IL-1细胞因子超家族的成员,被认为是免疫反应的重要调节因子。本研究的目的是调查特发性肾病综合征(INS)患儿复发期和缓解期血清及尿液中的IL-18水平,并评估IL-18在该疾病中的作用。
本研究纳入了67例3至16岁的INS患儿和15例正常对照。根据疾病活动度将患者分为两组:I组(n = 37)——INS复发组,II组(n = 30)——INS缓解组。采用酶联免疫吸附测定法(ELISA)测定血清和尿液中的IL-18,并以尿肌酐(Cr)浓度校正尿液结果。检测INS患儿的血清肌酐、蛋白、白蛋白及24小时蛋白尿。
I组尿IL-18浓度(213.51±162.15 pg/mg Cr)显著高于II组(64.74±10.95 pg/mg Cr)和正常对照组(37.03±4.1 pg/mg Cr,p<0.001)。I组血清IL-18浓度显著高于对照组(分别为146.4±30.2和113±10 pg/ml;p<0.05);I组与II组之间以及II组与对照组之间的差异均无统计学意义。尿IL-18与血清IL-18及尿蛋白排泄呈正相关,但与其他实验室数据无相关性。
INS复发期血清和尿液IL-18水平升高。这些发现表明INS活动期与IL-18水平之间存在关联,并提示该细胞因子在INS发病过程中的作用。INS病程中尿IL-18排泄的变化与疾病活动度相关。